QLGN Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system...

Stats
Dagens volum	9 087.00
Gjennomsnittsvolum	65 834.00
Markedsverdi	1.83M
EPS	$-0.640 ( 2023-11-14 )
Neste inntjeningsdato	( $-0.520 ) 2024-05-21
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.120
ATR14	$0.00700 (2.41%)

Insider Trading

Date	Person	Action	Amount	type
2022-07-11	Abdul-ahad Wajdi	Buy	80 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Lotz Christopher L.	Buy	100 000	Stock Option (Right to Buy)
2022-07-11	Arshad Tariq	Buy	102 000	Stock Option (Right to Buy)
2022-07-11	Ritter Ira E.	Buy	40 000	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 89 transactions
Buy: 8 588 032 \| Sell: 1 076 061

Qualigen Therapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
LYEL	0.959
ARQQ	0.958
WISA	0.956
FATE	0.954
QTEK	0.953
RPID	0.953
STRC	0.951
NKTX	0.951
LYRA	0.945
GROM	0.944

10 Mest negative korrelasjoner
LRFC	-0.955
NWFL	-0.954
STAY	-0.944
LUNA	-0.941
TIPT	-0.939
IBEX	-0.938
IVAC	-0.936
PEBK	-0.935
GLLI	-0.931
CCRC	-0.931

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Qualigen Therapeutics Inc Økonomi

Annual	2023
Omsetning:	$0
Bruttogevinst:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2023
Omsetning:	$0
Bruttogevinst:	$-4 495.00 (0.00 %)
EPS:	$-2.53

FY	2022
Omsetning:	$4.98M
Bruttogevinst:	$680 801 (13.66 %)
EPS:	$-5.48

FY	2021
Omsetning:	$5.65M
Bruttogevinst:	$1.32M (23.37 %)
EPS:	$-6.10

Financial Reports:

No articles found.

Qualigen Therapeutics Inc

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.